PHIO Q2 2022 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$3M

Net Income

-$3M

EPS (Diluted)

$-20.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$83,000

Balance Sheet

Total Assets

$20M

Total Liabilities

$3M

Stockholders' Equity

$17M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	$0	—
Operating Income	-$3M	-$3M	+6.1%
Net Income	-$3M	-$3M	+5.8%